Capsoil

What Capsoil does

Capsoil Technologies Ltd. is a privately held Israeli biotechnology company founded in 2018 and headquartered in Israel with a US regional headquarters in New York and additional offices in Montreal, Los Angeles, Chicago, and St George. The company develops and licenses Liposoll™, a patented liposomal powder delivery platform (US Patent 11,712,430 B2) that converts hydrophobic oil-based active ingredients into shelf-stable, water-dispersible nanometric powders with particle sizes of approximately 150–200 nm and active loads exceeding 60%, compared to an industry norm of 5–10%. The platform supports dual-polarity encapsulation of both hydrophilic and lipophilic compounds in a single particle, enabling claimed bioavailability improvements of up to 6× over standard oil-based formats and 2-year dry-shelf stability without refrigeration or emulsifiers.

Capsoil monetizes Liposoll™ as a B2B raw-material ingredient, selling its encapsulated powders on a quote basis to manufacturers and formulators across four industry verticals: nutraceuticals and dietary supplements (vitamins A/D/E/K, Omega-3, Astaxanthin, and other bioactives), hemp and cannabis (water-dispersible cannabinoid powders for edibles and topicals), cosmetics and skin care (Retinol, Hyaluronic acid, and other cosmeceutical actives), and agriculture (pesticides, fertilizers, livestock feed, and biocides). The go-to-market is consultative enterprise sales, supported by vertical-specific landing pages and clinical data sets that substantiate performance claims in each application.

The company operates as a bootstrapped, founder-led entity with 11–50 employees and no disclosed institutional funding rounds, public listing, parent company, or named commercial customers. The management team disclosed in public materials is limited to a single named individual, Rafael Ezra, who serves as a Founding Member and CTO, while CEO, CFO, and other C-suite roles are not represented in the available data.

Name

Capsoil

Legal name

Capsoil Technologies Ltd.

Website

https://capsoil.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Capsoil Technologies Ltd. is a privately held Israeli biotech that sells Liposoll™, a patented liposomal powder delivery platform, to B2B manufacturers in nutraceuticals, hemp and cannabis, cosmetics, and agriculture for converting oil-based actives into shelf-stable, water-soluble nanometric powders.

Ownership category

akta.pro rank

Product category

Liposomal Powder Ingredients

NAICS

Starch and Vegetable Fats and Oils Manufacturing (31122)

SIC

Miscellaneous Food Preparations & Kindred Products (2090)

akta.pro primary industry

Delivery Systems & Encapsulation (Microencapsulation, Liposomes, Emulsions, Beadlets, Spray-Dried) (AFAJAKAL)

akta.pro secondary industries

Encapsulation & Emulsified Delivery Systems (Spray-dried emulsions, Lipid microencapsulation) (AFAJACAL), Omega-3 & Specialty Lipids (Fish/Algal Oils, EPA/DHA, MCTs, CLA, Phospholipids) (AFAJAKAC), Flavor Encapsulation & Delivery Systems (Spray-Dried, Emulsions, Encapsulates) (AFAJADAJ), Fats, Oils & Lipid Ingredients (Specialty Oils, MCTs, Structured Lipids) (CRADAOAL)

Keywords

• Liposomal powder technology
• Bioavailability enhancement ingredients
• Nano encapsulation systems
• Lipid encapsulation ingredients
• Water-soluble active ingredients

Headquarters

HQ city

Shefayim

HQ country

Israel

HQ region

Middle East

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales

Revenue model

1. Liposoll™ Raw Material/Ingredient Sales: Capsoil sells its Liposoll™ liposomal powder as a B2B raw material ingredient to manufacturers in nutraceuticals, agriculture, cosmetics, and hemp & cannabis industries. Companies purchase the powder to incorporate into their own formulations (tablets, sachets, beverages, topicals). The company operates as a biotech ingredient supplier, providing proprietary encapsulated powders that enhance the bioavailability of oil-based actives in customer products.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Capsoil develops and commercializes Liposoll™, a patented liposomal powder delivery system that converts hydrophobic, oil-based actives into water-dispersible, shelf-stable nanometric powders of approximately 150-200nm. The company supplies these B2B specialty powder ingredients to manufacturers and formulators in the nutraceutical, agricultural, cosmetics, and hemp & cannabis industries, enabling improved bioavailability, water solubility, and easier incorporation of lipophilic compounds into finished products without traditional emulsification steps.

Product overview

Capsoil offers Liposoll™, a patented liposomal powder delivery platform that transforms oil-based actives into clean-label, shelf-stable, water-soluble nanometric powders. The core technology delivers 6x greater bioavailability than conventional formats, operates at 60%+ active loads, and self-emulsifies upon contact with water. The company applies this technology across four industry verticals: Nutraceuticals (vitamins, Omega-3, supplements), Agriculture (pesticides, fertilizers, feed), Cosmetics (Retinol, Hyaluronic acid), and Hemp & Cannabis (CBD, cannabinoids). All verticals use the same Liposoll™ platform with industry-specific formulations and applications.

Differentiator

Problem solved

Functional benefit

Products and services

• Liposoll™
• Nutraceutical-grade Liposoll Ingredients
• Agricultural-grade Liposoll Ingredients
• Cosmetics-grade Liposoll Ingredients
• Hemp & Cannabis-grade Liposoll Ingredients

Quantifiable outcome

• Up to 6× greater bioavailability compared to traditional oil-based actives
• +12 more outcomes

Segments4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• Lycored: Supplier of carotenoid and lipid-based nutraceutical ingredients with proprietary encapsulation/delivery formats for vitamins, antioxidants, and colorants. Comparable as a B2B supplier of value-added lipid-encapsulated bioactives with vertical overlap in nutraceuticals and cosmetics.
• SourceOne Global Partners (VESIsorb): Distributor/technology partner behind the VESIsorb lipid-based nutrient delivery system for nutraceuticals. Directly comparable to Capsoil's mission of enhancing bioavailability of oil-based actives via proprietary lipid delivery, serving overlapping supplement manufacturer customers.
• Lipoid GmbH: Specialty phospholipid and liposome ingredient manufacturer supplying encapsulated lipid systems to pharma, nutraceutical, and cosmetic formulators. Closest pure-play comparator to Capsoil's Liposoll™ liposomal powder platform given its lipid-based delivery focus and B2B ingredient model.
• ABITEC Corporation: Manufacturer of specialty lipid excipients and self-emulsifying drug delivery systems (SEDDS) for pharma and nutraceutical applications. Comparable technology stack (functional lipids, self-emulsifying systems) and overlapping B2B ingredient customer base in regulated nutraceutical/pharma markets.

Broad incumbents

• Givaudan: Largest flavors and fragrances house globally, with an expanding specialty ingredients and natural extract business serving food, beverage, and cosmetic customers. Touches Capsoil's space through encapsulation and bioactive delivery formats but as part of a much broader portfolio.
• IFF (International Flavors & Fragrances): Global ingredient house spanning flavors, fragrances, food ingredients, and encapsulation technologies across nutraceutical and cosmetic markets. Comparable as a competing supplier of encapsulated actives and delivery systems, though Capsoil specializes narrowly in liposomal powders.
• DSM-Firmenich: Global nutrition, health, and specialty ingredients major with broad portfolios in vitamins, Omega-3, and encapsulated bioactives. Overlaps with Capsoil across nutraceutical actives, lipids, and encapsulation formats, but operates as a broad incumbent rather than a pure liposomal-powder specialist.
• BASF Nutrition & Health: Major supplier of vitamins, carotenoids, and lipid-based nutraceutical ingredients with extensive encapsulation capabilities. Highly comparable in product categories (lipids, fat-soluble vitamins, encapsulated actives) but at meaningfully greater scale and broader portfolio than Capsoil.
• Cargill Health Technologies: Global agribusiness with health-ingredient operations spanning specialty oils, lecithin/phospholipids, and encapsulated bioactives. Comparable in agricultural and nutraceutical lipid inputs, particularly to Capsoil's agriculture and nutraceutical verticals.

Emerging players

• Sphera Encapsulation: Specialist microencapsulation CDMO/ingredient developer offering encapsulated powders and lipid-based delivery systems for food, nutraceutical, and cosmetic customers. Highly comparable emerging player operating with similar encapsulation B2B model in overlapping verticals.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/capsoil

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Capsoil